Efficacy of acetylleucine in vertigo and dizziness: a systematic review of randomised controlled trials

Abstract : PURPOSE: To assess the efficacy of acetylleucine to improve or stop an attack of vertigo and dizziness (vertigo/dizziness). METHODS: Systematic review by 2 independent reviewers. Consultation of the Medline, Cochrane and ClinicalTrials.gov databases until September 2018. Keywords used: Acetylleucine, Tanganil®, Acetyl-DL-leucine, Acetyl-leucine. Trial selection: randomised controlled trials (RCTs) comparing acetylleucine against placebo. RESULTS: Up until 2018, no RCTs have been published on the efficacy of acetylleucine in vertigo/dizziness. CONCLUSION: There is no solid evidence of the efficacy of acetylleucine in vertigo/dizziness. Given its frequent prescription and the cost generated for the French social security system, high-quality randomised trials should be carried out to assess its efficacy.
Document type :
Journal articles
Complete list of metadatas

Cited literature [42 references]  Display  Hide  Download

https://hal-clermont-univ.archives-ouvertes.fr/hal-01978421
Contributor : Alexine Vignal <>
Submitted on : Friday, June 14, 2019 - 1:53:56 PM
Last modification on : Friday, July 5, 2019 - 1:21:22 AM

Annex


Identifiers

Citation

Paul Vanderkam, Clara Blanchard, Florian Naudet, Denis Pouchain, Hélène Vaillant Roussel, et al.. Efficacy of acetylleucine in vertigo and dizziness: a systematic review of randomised controlled trials. European Journal of Clinical Pharmacology, Springer Verlag, 2019, 75 (5), pp.603-607. ⟨10.1007/s00228-018-02617-6⟩. ⟨hal-01978421⟩

Share

Metrics

Record views

83

Files downloads

12